Additive Solutions for the Suspension of Blood Products Framework Agreement

Description

Establishment of a Framework Agreement with the following Blood Establishments as<br/>beneficiaries - NHS Blood and Transplant; the Welsh Blood Service (WBS); the Northern<br/>Ireland Blood Transfusion Service (NIBTS); the Scottish National Blood Transfusion Service<br/>(SNBTS); the Australian Red Cross Lifeblood (ARCL), the New Zealand Blood Service<br/>(NZBS) and the Irish Blood Transfusion Service (IBTS).<br/>Additive Solutions for the Suspension of Blood Products:<br/>Lot 1: Additive solution for the suspension of pooled platelets, granulocytes and other<br/>components derived from whole blood; Additive solution for the suspension of single donor<br/>apheresis derived platelets;<br/>Lot 2: SAGM solution for the routine washing and re-suspension of red cells<br/>during the production of specialist blood components in accordance with the Guidelines for<br/>the Blood Transfusion Services in the UK details of which can be found at the following<br/>website https://www.transfusionguidelines.org/red-book